ABCA transporter gene expression and poor outcome in epithelial ovarian cancer

Journal of the National Cancer Institute

Volumn 106, Issue 7, 2014, Pages

  Hedditch, Ellen L ^a   Gao, Bo ^b   Russell, Amanda J ^a   Lu, Yi ^d   Emmanuel, Catherine ^b   Beesley, Jonathan ^d   Johnatty, Sharon E ^d   Chen, Xiaoqing ^d   Harnett, Paul ^c   George, Joshy ^e   Williams, Rebekka T ^a   Flemming, Claudia ^a   Lambrechts, Diether ^f   Despierre, Evelyn ^g   Lambrechts, Sandrina ^g   Vergote, Ignace ^g   Karlan, Beth ^h   Lester, Jenny ^h   Orsulic, Sandra ^h   Walsh, Christine ^h   Fasching, Peter ^i,j   Beckmann, Matthias W ⁱ   Ekici, Arif B ^k   Hein, Alexander ⁱ   Matsuo, Keitaro ^k   Hosono, Satoyo ^k   Nakanishi, Toru ^l   Yatabe, Yasushi ^k   Pejovic, Tanja ^m,n   Bean, Yukie ^m,n   Heitz, Florian ^o,p,q   Harter, Philipp ^r   Du Bois, Andreas ^r   Schwaab, Ira ^r   Hogdall, Estrid ^s,t   Kjaer, Susan K ^l,s   Jensen, Allan ^s   Hogdall, Claus ^u   Lundvall, Lene ^u   Engelholm, Svend Aage ^t   Brown, Bob ^v   Flanagan, James ^v   Metcalf, Michelle D ^v   Siddiqui, Nadeem ^w   Sellers, Thomas ^x   Fridley, Brooke ^l   Cunningham, Julie ^y   Schildkraut, Joellen ^l,aa   Iversen, Ed ^ab   Weber, Rachel P ^l   Berchuck, Andrew ^z   Goode, Ellen ^l   Bowtell, David D ^e   Chenevix Trench, Georgia ^d   Defazio, Anna ^b   Norris, Murray D ^a   Macgregor, Stuart ^d   Haber, Michelle ^a   Henderson, Michelle J ^a   more..

^a CHILDREN S CANCER INSTITUTE AUSTRALIA FOR MEDICAL RESEARCH   (Australia)

^b WESTMEAD HOSPITAL   (Australia)

^c UNIVERSITY OF SYDNEY   (Australia)

^d QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^e PETER MACCALLUM CANCER CENTRE   (Australia)

^f DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^g UNIVERSITY OF LEUVEN   (Belgium)

^h CEDARS SINAI MEDICAL CENTER   (United States)

ⁱ UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^j UNIVERSITY OF CALIFORNIA   (United States)

^k AICHI CANCER CENTER HOSPITAL   (Japan)

^l Department of Gynecology ^*  (United States)

^m OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

ⁿ OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^o UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^p KLINIKEN ESSEN MITTE   (Germany)

^q DR HORST SCHMIDT KLINIKEN   (Germany)

^r Institut Für Humangenetik Wiesbaden   (Germany)

^s DANISH CANCER SOCIETY RESEARCH CENTER   (Denmark)

^t UNIVERSITY OF COPENHAGEN   (Denmark)

^u Gynecology Clinic   (Denmark)

^v IMPERIAL COLLEGE LONDON   (United Kingdom)

^w UNIVERSITY OF GLASGOW   (United Kingdom)

^x H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^y MAYO CLINIC   (United States)

^z DUKE UNIVERSITY MEDICAL CENTER   (United States)

^aa DUKE CANCER INSTITUTE   (United States)

^ab Duke University   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

SMALL INTERFERING RNA;

ABCA TRANSPORTER GENE; ABCA1 GENE; ABCA6 GENE; ABCA8 GENE; ABCA9 GENE; ALLELE; ARTICLE; CANCER CELL; CANCER GROWTH; CANCER STAGING; CELL MIGRATION; CONTROLLED STUDY; CYTOREDUCTIVE SURGERY; FEMALE; GENE; GENE EXPRESSION; GENE REPRESSION; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MAJOR CLINICAL STUDY; OVARY CARCINOMA; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; SINGLE NUCLEOTIDE POLYMORPHISM;

ATP BINDING CASSETTE TRANSPORTER 1; ATP-BINDING CASSETTE TRANSPORTERS; CELL MOVEMENT; CYSTADENOCARCINOMA, SEROUS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENOME-WIDE ASSOCIATION STUDY; HUMANS; KAPLAN-MEIER ESTIMATE; NEOPLASM GRADING; NEOPLASMS, GLANDULAR AND EPITHELIAL; NEOPLASTIC STEM CELLS; OVARIAN NEOPLASMS; POLYMORPHISM, SINGLE NUCLEOTIDE; REAL-TIME POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 84905247012     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/dju149     Document Type: Article

References (40)

1. Levi F, Lucchini F, Negri E, et al. Cancer mortality in Europe, 1995-1999, and an overview of trends since 1960. Int J Cancer. 2004;110(2):155-169.
2. Dean M. The genetics of ATP-binding cassette transporters. Methods Enzymol. 2005;400:409-429.
3. Szakacs G, Annereau JP, Lababidi S, et al. Predicting drug sensitivity and resistance: profiling ABC transporter genes in cancer cells. Cancer Cell. 2004;6(2):129-137.
4. Fletcher JI, Haber M, Henderson MJ, et al. ABC transporters in cancer: more than just drug efflux pumps. Nat Rev Cancer. 2010;10(2):147-156.
5. Wang D, Dubois RN. Eicosanoids and cancer. Nat Rev Cancer. 2010;10(3):181-193.
6. Henderson MJ, Haber M, Porro A, et al. ABCC multidrug transporters in childhood neuroblastoma: clinical and biological effects independent of cytotoxic drug efflux. J Natl Cancer Inst. 2011;103(16):1236-1251.
7. Nieman KM, Kenny HA, Penicka CV, et al. Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth. Nat Med. 2011;17(11):1498-1503.
8. Pyragius CE, Fuller M, Ricciardelli C, et al. Aberrant lipid metabolism: An emerging diagnostic and therapeutic target in ovarian cancer. Int J Mol Sci. 2013;14(4):7742-7756.
9. Rask K, Zhu Y, Wang W, et al. Ovarian epithelial cancer: A role for PGE2-synthesis and signaling in malignant transformation and progression. Mol Cancer. 2006;5:62.
10. Seo JM, Park S, Kim JH: Leukotriene B4 receptor-2 promotes invasiveness and metastasis of ovarian cancer cells through signal transducer and activator of transcription 3 (STAT3)-dependent up-regulation of matrix metalloproteinase 2 J Biol Chem. 2012;287(17):13840-13849.
11. Etemadmoghadam D, deFazio A, Beroukhim R, et al. Integrated genomewide DNA copy number and expression analysis identifies distinct mechanisms of primary chemoresistance in ovarian carcinomas. Clin Cancer Res. 2009;15:(4)1417-1427.
12. Tothill RW, Tinker AV, George J, et al. Novel molecular subtypes of serous and endometrioid ovarian cancer linked to clinical outcome. Clin Cancer Res. 2008;14:(16)5198-5208.
13. The Cancer Genome Atlas. Integrated genomic analyses of ovarian carcinoma. Nature. 2011;474(7353):609-615.
14. Johnatty SE, Beesley J, Gao B, et al. ABCB1 (MDR1) polymorphisms and ovarian cancer progression and survival: A comprehensive analysis from the Ovarian Cancer Association Consortium and The Cancer Genome Atlas. Gynecol Oncol. 2013;131(2013):8-14.
15. Haber M, Smith J, Bordow SB, et al. Association of high-level MRP1 expression with poor clinical outcome in a large prospective study of primary neuroblastoma. J Clin Oncol. 2006;24(10):1546-1553.
16. Vandesompele J, De Preter K, Pattyn F, et al. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol. 2002;3(7):RESEARCH0034.
17. Chenevix-Trench G, Kerr J, Friedlander M, et al. Homozygous deletions on the short arm of chromosome 9 in ovarian adenocarcinoma cell lines and loss of heterozygosity in sporadic tumors. Am J Hum Genet. 1994;55(1):143-149.
18. Helland A, Anglesio MS, George J, et al: Deregulation of MYCN, LIN28B and LET7 in a molecular subtype of aggressive high-grade serous ovarian cancers. PLoS One. 2011;6 e18064.
19. Bentink S, Haibe-Kains B, Risch T, et al. Angiogenic mRNA and micro-RNA gene expression signature predicts a novel subtype of serous ovarian cancer. PLoS One. 2012;7(2):e30269.
20. Murai T, Maruyama Y, Mio K, et al: Low cholesterol triggers membrane microdomain-dependent CD44 shedding and suppresses tumor cell migration. J Biol Chem. 2011;286(3):1999-2007.
21. Sun M, Northup N, Marga F, et al. The effect of cellular cholesterol on membrane-cytoskeleton adhesion. J Cell Sci. 2007;120(Pt 13):2223-2231.
22. Mack JT, Beljanski V, Tew KD, et al. The ATP-binding cassette transporter ABCA2 as a mediator of intracellular trafficking. Biomed Pharmacother. 2006;60(9):587-592.
23. Jessup W, Gelissen IC, Gaus K, et al. Roles of ATP binding cassette transporters A1 and G1, scavenger receptor BI and membrane lipid domains in cholesterol export from macrophages. Curr Opin Lipidol. 2006;17(3):247-257.
24. Kim J, Adam RM, Solomon KR, et al. Involvement of cholesterol-rich lipid rafts in interleukin-6-induced neuroendocrine differentiation of LNCaP prostate cancer cells. Endocrinology. 2004;145(2):613-619.
25. Rezen T. The impact of cholesterol and its metabolites on drug metabolism. Expert Opin Drug Metab Toxicol. 2011;7(4):387-398.
26. Troost J, Lindenmaier H, Haefeli WE, et al. Modulation of cellular cholesterol alters P-glycoprotein activity in multidrug-resistant cells. Mol Pharmacol. 2004;66(5):1332-1339.
27. Smith B, Land H. Anticancer activity of the cholesterol exporter ABCA1 gene. Cell Rep. 2012;2(3):580-590.
28. Mack JT, Brown CB, Tew KD. ABCA2 as a therapeutic target in cancer and nervous system disorders. Expert Opin Ther Targets. 2008;12(4):491-504.
29. Nielsen SF, Nordestgaard BG, Bojesen SE: Statin use and reduced cancerrelated mortality. N Engl J Med. 2012;367(19):1792-1802.
30. Li AJ, Elmore RG, Chen IY, et al. Serum low-density lipoprotein levels correlate with survival in advanced stage epithelial ovarian cancers. Gynecol Oncol. 2010;116(1):78-81.
31. Peelman F, Labeur C, Vanloo B, et al. Characterization of the ABCA transporter subfamily: identification of prokaryotic and eukaryotic members, phylogeny and topology. J Mol Biol. 2003;325(2):259-274.
32. Li G, Shi P, Wang Y. Evolutionary dynamics of the ABCA chromosome 17q24 cluster genes in vertebrates. Genomics. 2007;89(3):385-391.
33. Bast RC Jr, Hennessy B, Mills GB. The biology of ovarian cancer: new opportunities for translation. Nat Rev Cancer. 2009;9(6):415-428.
34. von Otte S, Paletta JR, Becker S, et al. Follicular fluid high density lipoprotein-associated sphingosine 1-phosphate is a novel mediator of ovarian angiogenesis. J Biol Chem. 2006;281(9):5398-5405.
35. Becker S, von Otte S, Robenek H, et al. Follicular fluid high-density lipoprotein-associated sphingosine 1-phosphate (S1P) promotes human granulosa lutein cell migration via S1P receptor type 3 and small G-protein RAC1. Biol Reprod. 2011;84(3):604-612.
36. Park KS, Kim MK, Lee HY, et al. S1P stimulates chemotactic migration and invasion in OVCAR3 ovarian cancer cells. Biochem Biophys Res Commun. 2007;356(1):239-244.
37. Wang D, Zhao Z, Caperell-Grant A, et al. S1P differentially regulates migration of human ovarian cancer and human ovarian surface epithelial cells. Mol Cancer Ther. 2008;7(7):1993-2002.
38. Alvarez SE, Milstien S, Spiegel S. Autocrine and paracrine roles of sphingosine-1-phosphate. Trends Endocrinol Metab. 2007;18(8):300-307.
39. Lee MJ, Thangada S, Claffey KP, et al. Vascular endothelial cell adherens junction assembly and morphogenesis induced by sphingosine-1-phosphate. Cell. 1999;99(3):301-312.
40. Visentin B, Vekich JA, Sibbald BJ, et al. Validation of an anti-sphingosine-1-phosphate antibody as a potential therapeutic in reducing growth, invasion, and angiogenesis in multiple tumor lineages. Cancer Cell. 2006;9(3):225-238